-------------------------------
OMB APPROVAL
-------------------------------
OMB Number: 3235-0060
-------------------------------
Expires: March 31, 2006
-------------------------------
Estimated average burden
Hours per response: 2.64
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 23, 2004
------------------------------
Celsion Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-14242 52-1256615
---------------------------- ---------------------- --------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
10220-L Old Columbia Road, Columbia, Maryland 21046-1705
--------------------------------------------------------------------------------
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (410) 290-5390
---------------------------
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS
Effective February 23, 2004, the Registrant entered into a Separation
and Release Agreement with Daniel S. Reale (the "Separation Agreement"), in
connection with Mr. Reale's resignation as an Executive Vice President and
President of the Company's Oncology Division. A copy of the Separation Agreement
letter is attached as Exhibit 99.1 to this Report on Form 8-K.
On February 23, 2004, the Registrant issued a press release announcing
Mr. Reale's resignation. A copy of the press release is attached as Exhibit 99.2
to this Report on Form 8-K.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CELSION CORPORATION
Date: March 1, 2004 By: /s/ Anthony P. Deasey
------------- -------------------------------------------
Executive Vice President--Finance and
Administration and Chief Financial Officer
-3-
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Separation and Release Agreement between the Registrant and Daniel
S. Reale
99.2 Registrant's Press Release date February 23, 2004